BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17697978)

  • 1. Generation and characterization of islet cell tumor in pTet-on/pTRE-SV40Tag double-transgenic mice model.
    Shen Q; Sun Q; Wei X; Dong J; Zhang R; Wu P; Jin Y; Feng J; Li H; Hu Y
    J Biosci Bioeng; 2007 Jul; 104(1):14-21. PubMed ID: 17697978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of insulin-like growth factor-insulin receptor signal pathway in the transgenic mouse model of medulloblastoma.
    Sun Q; Wei X; Feng J; Zhang R; Shen Q; Dong J; Jin Y; Dong S; Li H; Hu Y
    Cancer Sci; 2008 Feb; 99(2):234-40. PubMed ID: 18271920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis.
    Christofori G; Naik P; Hanahan D
    Nature; 1994 Jun; 369(6479):414-8. PubMed ID: 7910953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis.
    Müller-Hermelink N; Braumüller H; Pichler B; Wieder T; Mailhammer R; Schaak K; Ghoreschi K; Yazdi A; Haubner R; Sander CA; Mocikat R; Schwaiger M; Förster I; Huss R; Weber WA; Kneilling M; Röcken M
    Cancer Cell; 2008 Jun; 13(6):507-18. PubMed ID: 18538734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended life span is associated with insulin resistance in a transgenic mouse model of insulinoma secreting human islet amyloid polypeptide.
    Andrikopoulos S; Hull RL; Verchere CB; Wang F; Wilbur SM; Wight TN; Marzban L; Kahn SE
    Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E418-24. PubMed ID: 14613923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene.
    Efrat S; Fusco-DeMane D; Lemberg H; al Emran O; Wang X
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3576-80. PubMed ID: 7724601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and characterization of a transgenic mouse model for pancreatic cancer.
    Sun Q; Feng J; Wei XL; Zhang R; Dong SZ; Shen Q; Dong J; Li HD; Hu YH
    World J Gastroenterol; 2006 May; 12(17):2785-8. PubMed ID: 16718771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of colonic and pancreatic endocrine tumours in mice expressing a glucagon-SV40 T antigen transgene.
    Asa SL; Lee YC; Drucker DJ
    Virchows Arch; 1996 Mar; 427(6):595-606. PubMed ID: 8605571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of prostate cancer from a subset of p63-positive basal epithelial cells in FG/Tag transgenic mice.
    Reiner T; de Las Pozas A; Parrondo R; Perez-Stable C
    Mol Cancer Res; 2007 Nov; 5(11):1171-9. PubMed ID: 17982114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model.
    Zhang G; Chi Y; Du YN
    J Vis Exp; 2017 Oct; (128):. PubMed ID: 29155705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of SV40 T antigen gene in the oligodendroglia induced primitive neuroectodermal tumor-like tumors in the mouse brain.
    Konishi S; Naora H; Kimura M; Sato M; Nagasaki M; Yokoyama M; Otani H; Moritake K; Katsuki M
    Congenit Anom (Kyoto); 2004 Dec; 44(4):215-24. PubMed ID: 15566412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine Tumors of the Pancreas in Transgenic Mice.
    Longnecker DS
    Comp Med; 2004 Feb; 54(1):21-2. PubMed ID: 15382338
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperplasia and tumors of the islets of Langerhans in mice bearing an elastase I-SV40 T-antigen fusion gene.
    Bell RH; Memoli VA; Longnecker DS
    Carcinogenesis; 1990 Aug; 11(8):1393-8. PubMed ID: 2167183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes.
    Robertson K; Lu Y; De Jesus K; Li B; Su Q; Lund PK; Liu JL
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E928-38. PubMed ID: 18270301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a neuroendocrine gene signature in gastric tumor cells from CEA 424-SV40 large T antigen-transgenic mice depends on SV40 large T antigen.
    Ihler F; Vetter EV; Pan J; Kammerer R; Debey-Pascher S; Schultze JL; Zimmermann W; Enders G
    PLoS One; 2012; 7(1):e29846. PubMed ID: 22253802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partially circumventing peripheral tolerance for oncogene-specific prostate cancer immunotherapy.
    Neeley YC; Arredouani MS; Hollenbeck B; Eng MH; Rubin MA; Sanda MG
    Prostate; 2008 May; 68(7):715-27. PubMed ID: 18302222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and characterization of JSRV envelope transgenic mice in FVB background.
    Chitra E; Yu SL; Hsiao KN; Shao HY; Sia C; Chen IH; Hsieh SY; Chen JH; Chow YH
    Virology; 2009 Oct; 393(1):120-6. PubMed ID: 19695657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation, hyperplasia, neogenesis, and neoplasia in the islets of Langerhans.
    Ballian N; Hu M; Liu SH; Brunicardi FC
    Pancreas; 2007 Oct; 35(3):199-206. PubMed ID: 17895838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous autoimmunity sufficiently potent to induce diabetes mellitus is insufficient to protect against insulinoma.
    Zwicker K; Chatten C; Gratton K; Demetrick D; Serra P; Shameli A; Santamaria P; Bathe OF
    J Immunol; 2009 Aug; 183(3):1705-14. PubMed ID: 19570832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models and cell lines of pancreatic neuroendocrine tumors.
    Babu V; Paul N; Yu R
    Pancreas; 2013 Aug; 42(6):912-23. PubMed ID: 23851429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.